Non-endocrine late complications in children after allogeneic haematopoietic SCT

被引:37
作者
Faraci, M. [1 ]
Bekassy, A. N. [2 ]
De Fazio, V. [1 ]
Tichelli, A. [3 ]
Dini, G. [1 ]
机构
[1] G Gaslini Inst Children, Bone Marrow Transplantat Unit, Dept Hematol & Oncol, I-16147 Genoa, Italy
[2] Univ Lund Hosp, Dept Hematol, S-22185 Lund, Sweden
[3] Univ Hosp Haematol Petersgraben, Dept Haematol, Basel, Switzerland
关键词
late complications; follow-up; recommendations;
D O I
10.1038/bmt.2008.55
中图分类号
Q6 [生物物理学];
学科分类号
071011 [生物物理学];
摘要
Non-endocrine events represent a heterogeneous group of complications occurring in children who survive long term after haematopoietic SCT. This review highlights the late sequel in a growing child. The preparative regimen itself with high-dose chemotherapy and/or radiotherapy (TBI) or the treatment given before the transplant procedure may cause organ damage with permanent sequel. Immune reconstitution and chronic GvHD have crucial role in occurrence of clinical abnormalities and late severe infections. Autoimmune syndromes may occur after use of novel transplant modalities (cord blood transplantation, reduced intensity conditioning regimen and haploidentical T-cell-depleted SCTs). Exposure to chemo- and/or radiotherapy increases the risk of second malignant neoplasms. Surveillance strategy focusing on each potential complication risk at continuous follow-up will allow vigilant post transplant care. Each paediatrician must be well versed in appropriate monitoring of these complications. Guidelines and recommendations are provided for serious problems occurring at follow-up, which must rapidly be identified so that appropriate intervention can be initiated. To achieve cure at a lowest possible price in terms of suffering and cost expenditures for health care is an extended frontier of paediatric haematopoietic SCT and biggest challenge for a paediatrician.
引用
收藏
页码:S49 / S57
页数:9
相关论文
共 54 条
[1]
Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation [J].
Afessa, B ;
Litzow, MR ;
Tefferi, A .
BONE MARROW TRANSPLANTATION, 2001, 28 (05) :425-434
[2]
New malignancies after blood or marrow stem-cell transplantation in children and adults: Incidence and risk factors [J].
Baker, KS ;
Defor, TE ;
Burns, LJ ;
Ramsay, NKC ;
Neglia, JP ;
Robison, LL .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) :1352-1358
[3]
Evaluating survivors of pediatric cancer [J].
Bhatia, S ;
Landier, W .
CANCER JOURNAL, 2005, 11 (04) :340-354
[4]
BISHOP M, 2002, BLOOD MARROW TRANSPL, V12, P4
[5]
Atypical retinal microvasculopathy after bone marrow transplantation [J].
Bylsma, GW ;
Hall, AJH ;
Szer, J ;
West, R .
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2001, 29 (04) :225-229
[6]
Long-lasting hypogammaglobulinemia following rituximab administration for Epstein-Barr virus-related post-transplant lymphoproliferative disease preemptive therapy [J].
Castagnola, E ;
Dallorso, S ;
Faraci, M ;
Morreale, G ;
Di Martino, D ;
Cristina, E ;
Scarso, L ;
Lanino, E .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2003, 12 (01) :9-10
[7]
Late pulmonary sequelae after childhood bone marrow transplantation [J].
Cerveri, I ;
Zoia, MC ;
Fulgoni, P ;
Corsico, A ;
Casali, L ;
Tinelli, C ;
Zecca, M ;
Giorgiani, G ;
Locatelli, F .
THORAX, 1999, 54 (02) :131-135
[8]
BONE-MARROW TRANSPLANT NEPHROPATHY - RADIATION NEPHRITIS REVISITED [J].
COHEN, EP ;
LAWTON, CA ;
MOULDER, JE .
NEPHRON, 1995, 70 (02) :217-222
[9]
Solid cancers after bone marrow transplantation [J].
Curtis, RE ;
Rowlings, PA ;
Deeg, HJ ;
Shriner, DA ;
Socie, G ;
Travis, LB ;
Horowitz, MM ;
Witherspoon, RP ;
Hoover, RN ;
Sobocinski, KA ;
Fraumeni, JF ;
Boice, JD .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (13) :897-904
[10]
DISTURBANCES IN DENTAL DEVELOPMENT AFTER TOTAL-BODY IRRADIATION IN BONE-MARROW TRANSPLANT RECIPIENTS [J].
DAHLLOF, G ;
BARR, M ;
BOLME, P ;
MODEER, T ;
LONNQVIST, B ;
RINGDEN, O ;
HEIMDAHL, A .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1988, 65 (01) :41-44